SCHEMBL31703317

SCHEMBL31703317

N#Cc1cc(NC(=O)Cn2nc(-c3ccccc3)ccc2=O)ccc1F

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.57
▸ ALDH1A1 P00352 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ ADRB2 P07550 1/20 0.57
▸ PKM P14618 1/20 0.57
▸ LMNA P02545 4/20 0.57
▸ MAPT P10636 4/20 0.55
▸ USP2 O75604 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ TSHR P16473 2/20 0.51
▸ TP53 P04637 2/20 0.51
▸ HTT P42858 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ POLB P06746 1/20 0.49
▸ HPGD P15428 1/20 0.48
▸ GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31703482 0.83 KDM4E (0.67) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL31703451 0.82 ACHE (0.68) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL31703302 0.81 ACHE (0.65) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL31703309 0.80 ALDH1A1 (0.74) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL31703255 0.78 KDM4E (0.72) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL23495113 0.77 KDM4E (0.60) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL29436188 0.77 KDM4E (0.60) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL29436214 0.77 KDM4E (0.58) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL23495306 0.77 KDM4E (0.58) KDM4EALDH1A1MEN1KMT2AADRB2
SCHEMBL31703490 0.76 KDM4E (0.66) KDM4EALDH1A1MEN1KMT2AADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215121-A1 HEDGEHOG ACYLTRANSFERASE INHIBITORS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-10-16 — — WO disclosed
Send feedback